US FDA is set to reopen door to controversial compounds amid black market surge, political backing, and mounting concerns ...

A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about ...

Even as Eli Lilly gets underway with its next major obesity launch in Foundayo, an FDA document related to the oral treatment ...

The FDA may have approved Eli Lilly's oral weight-loss drug Foundayo in record time, but it still needs to see more safety ...

More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new ...

Unsupervised use of GLP-1 drugs in India is raising serious concerns about muscle loss, nutritional deficiencies, and ...

More than one in four people with Type 2 diabetes use GLP-1 receptor agonists, a class of widely prescribed medications. However, new research from ...

Nutrition researchers have spent decades building a case for a plant that most North Americans overlook entirely. Guava ...